Rathbones Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $469M | Buy |
953,908
+27,175
| +3% | +$14.7M | 1.87% | 9 |
|
|
2025
Q4 | $537M | Sell |
926,733
-15,658
| -2% | -$8.85M | 2.1% | 9 |
|
|
2025
Q3 | $457M | Buy |
942,391
+37,037
| +4% | +$17.2M | 1.86% | 11 |
|
|
2025
Q2 | $367M | Buy |
905,354
+63,364
| +8% | +$26.5M | 1.58% | 13 |
|
|
2025
Q1 | $419M | Buy |
841,990
+45,673
| +6% | +$24.7M | 2.02% | 9 |
|
|
2024
Q4 | $414M | Buy |
796,317
+48,825
| +7% | +$26.8M | 2.01% | 9 |
|
|
2024
Q3 | $462M | Buy |
747,492
+25,080
| +3% | +$14.8M | 2.33% | 8 |
|
|
2024
Q2 | $399M | Buy |
722,412
+37,954
| +6% | +$21.7M | 2.18% | 8 |
|
|
2024
Q1 | $398M | Buy |
684,458
+67,138
| +11% | +$37.7M | 2.3% | 8 |
|
|
2023
Q4 | $328M | Buy |
617,320
+48,350
| +8% | +$23.4M | 2.11% | 10 |
|
|
2023
Q3 | $288M | Buy |
568,970
+299,338
| +111% | +$160M | 2.09% | 10 |
|
|
2023
Q2 | $141M | Buy |
269,632
+39,663
| +17% | +$21.4M | 1.31% | 20 |
|
|
2023
Q1 | $133M | Buy |
229,969
+13,925
| +6% | +$7.85M | 1.36% | 21 |
|
|
2022
Q4 | $119M | Buy |
216,044
+13,651
| +7% | +$7.23M | 1.34% | 21 |
|
|
2022
Q3 | $103M | Buy |
202,393
+15,174
| +8% | +$8.49M | 1.27% | 22 |
|
|
2022
Q2 | $102M | Buy |
187,219
+7,393
| +4% | +$4.07M | 1.17% | 21 |
|
|
2022
Q1 | $106M | Buy |
179,826
+19,421
| +12% | +$11.2M | 1.08% | 22 |
|
|
2021
Q4 | $107M | Buy |
160,405
+13,400
| +9% | +$8.37M | 1.04% | 29 |
|
|
2021
Q3 | $84M | Buy |
147,005
+11,699
| +9% | +$6.42M | 0.9% | 34 |
|
|
2021
Q2 | $68.3M | Buy |
135,306
+27,465
| +25% | +$13M | 0.76% | 42 |
|
|
2021
Q1 | $49.2M | Buy |
107,841
+42,276
| +64% | +$20.2M | 0.63% | 51 |
|
|
2020
Q4 | $30.5M | Buy |
65,565
+31,300
| +91% | +$14.7M | 0.43% | 62 |
|
|
2020
Q3 | $15.1M | Buy |
34,265
+666
| +2% | +$275K | 0.26% | 78 |
|
|
2020
Q2 | $12.2M | Buy |
33,599
+22,957
| +216% | +$7.69M | 0.25% | 79 |
|
|
2020
Q1 | $3.02M | Buy |
10,642
+9,747
| +1,089% | +$3.07M | 0.09% | 122 |
|
|
2019
Q4 | $291K | Hold |
895
| – | – | 0.01% | 275 |
|
|
2019
Q3 | $261K | Hold |
895
| – | – | 0.01% | 284 |
|
|
2019
Q2 | $263K | Hold |
895
| – | – | 0.01% | 275 |
|
|
2019
Q1 | $245K | Sell |
895
-490
| -35% | -$122K | 0.01% | 275 |
|
|
2018
Q4 | $310K | Buy |
1,385
+290
| +26% | +$68K | 0.01% | 257 |
|
|
2018
Q3 | $267K | Hold |
1,095
| – | – | 0.01% | 261 |
|
|
2018
Q2 | $227K | Hold |
1,095
| – | – | 0.01% | 269 |
|
|
2018
Q1 | $226K | Sell |
1,095
-35
| -3% | -$7.35K | 0.01% | 279 |
|
|
2017
Q4 | $215K | Sell |
1,130
-25
| -2% | -$4.79K | 0.01% | 289 |
|
|
2017
Q3 | $219K | Hold |
1,155
| – | – | 0.01% | 283 |
|
|
2017
Q2 | $202K | Buy |
+1,155
| New | +$194K | 0.01% | 284 |
|
|
2014
Q3 | – | Sell |
-4,405
| Closed | -$520K | – | 314 |
|
|
2014
Q2 | $520K | Hold |
4,405
| – | – | 0.04% | 201 |
|
|
2014
Q1 | $530K | Buy |
+4,405
| New | +$524K | 0.04% | 191 |
|
|
2013
Q4 | – | Sell |
-5,405
| Closed | -$498K | – | 259 |
|
|
2013
Q3 | $498K | Hold |
5,405
| – | – | 0.06% | 175 |
|
|
2013
Q2 | $457K | Buy |
+5,405
| New | +$450K | 0.06% | 162 |
|
Other funds holding TMO
VCM
Rathbones Group's TMO Position: Q1 2026 in Review
Rathbones Group increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q1 2026, buying an estimated $14.7M and bringing the position to 953,908 shares worth $469M. The position accounts for 1.87% of the portfolio, ranked #9.
Rathbones Group first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $537M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Rathbones Group held 953,908 shares of Thermo Fisher Scientific worth $469M as of Q1 2026.
- Rathbones Group bought 27,175 Thermo Fisher Scientific shares in Q1 2026, an estimated $14.7M.
- Thermo Fisher Scientific made up 1.87% of Rathbones Group's portfolio in Q1 2026, its #9 holding.
- Rathbones Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
- Rathbones Group's Thermo Fisher Scientific position peaked at $537M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.